(Q34451561)

2 August 2017

title

Acetylation of procaine amide in man studied with a new gas chromatographic method (English)

1 reference

2 August 2017

Karlsson E

1

1 reference

2 August 2017

Molin L

series ordinal

2

1 reference

2 August 2017

Norlander B

series ordinal

3

1 reference

2 August 2017

Sjöqvist F

series ordinal

4

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 December 1974

1 reference

British Journal of Clinical Pharmacology

2 August 2017

published in

1 reference

2 August 2017

volume

1

1 reference

2 August 2017

issue

6

1 reference

2 August 2017

page(s)

467-475

1 reference

Procainamide induction of a systemic lupus erythematosus-like syndrome. Presentation of six cases, review of the literature, and analysis and followup of reported cases

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402529

The polymorphic acetylation of dapsone in man

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402529

The polymorphic acetylation of sulphapyridine in man

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402529

N-acetylprocainamide: an active metabolite of procainamide

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402529

Metabolism of procainamide in rhesus monkey and man

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402529

Plasma levels of procaine amide after administration of conventional and sustained-release tablets

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402529

Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402529

Antinuclear antibody induced by procainamide. A prospective study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402529

Genetic variations in the acetylation of isoniazid and other drugs

6 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1974.TB01696.X

Plasma levels of lidocaine during combined treatment with phenytoin and procainamide.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1974.TB01696.X

Procainamide Dosage Schedules, Plasma Concentrations, and Clinical Effects

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1974.TB01696.X

The physiological disposition and cardiac effects of procaine amide.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1402529

Pharmacokinetics of Procainamide

27 October 2018

1 reference

12 December 2020

Procainamide dosage schedules, plasma concentrations, and clinical effects

1 reference

12 December 2020

Inactivation of isoniazid (INH) in Swedish tuberculous patients before and during treatment with para-aminosalicylic acid (PAS)

1 reference

12 December 2020

P-AMINO-N-(2-(SUBSTITUTED AMINO)ETHYL)BENZAMIDES. POTENTIAL ANTIFIBRILLATORY DRUGS

1 reference

12 December 2020

The quantitative determination of isoniazid and para-aminosalicylic acid in body fluids

1 reference

12 December 2020

Arrhythmia prophylaxis with procaine amide: plasma concentrations in relation to dose

1 reference

12 December 2020

10.1111/J.1365-2125.1974.TB01696.X

Identifiers

DOI

1 reference

2 August 2017

1 reference

2 August 2017

1 reference